CRISPR/Cas9 2nd workshop
The popular CRISPR/Cas9 workshop was held for a second time January 12-13, 2015 at KI Science Park.
- Feng Zhang, Broad Institute of MIT
- Oscar Fernandez-Capetillo, KI
- Philip Hublitz, University of Oxford, WIMM
- Thoru Pederson, University of Massachusetts Medical School
- Vera Grinkevich, Wellcome Trust Sanger Institute
KI-Roche Oncology Workshop
The first KI-Roche Oncology workshop was held October 19-20, 2015 at Nobel Forum. The ambitions and ongoing efforts under the Master Collaboration Agreement (MCA, active since Dec. 2014) were introduced. Short scientific presentations were held by both parties, laying ground for discussions regarding possibilities for joint projects.
CRISPR/Cas9 1st workshop
The first StratCan workshop was held January 7-8, 2015 on CRISPR/Cas9. The workshop was a theory & hands on workshop teaching how to design and use the CRISPR/Cas9 system for in vitro (cells) and in vivo (mice) applications.
Invited speakers were leading researchers involved in developing this technique: Feng Zhang, Haoyi Wang, Kosuke Yusa and Vera Grinkevich. The workshop received great interest with over 70 applicants and the number of participants was therefore expanded from 30 to 45, including also international participants from Germany, France and the UK.
A joint 1-day symposium by BIOCON and KI on novel cancer therapy, was held at Nobel Forum April 25, 2014.
BIOCON, the Medicinal Bioconvergence Research Center (Director Sunghoon Kim) is based at Seoul National University and focuses on novel therapeutic target discovery and validation that can be further explored by the industry.